Vera E Valkhoff
Overview
Explore the profile of Vera E Valkhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lghoul-Oulad Said F, Hek K, Flinterman L, Herings R, Warle-van Herwaarden M, de Bie S, et al.
Pharmacoepidemiol Drug Saf
. 2020 Oct;
29(12):1659-1668.
PMID: 33051958
Purpose: In 2009 a Dutch guideline was published containing recommendations to reduce Hospital Admissions Related to Medications (HARMs). This study aims to examine time-trends of HARMs and their potential preventability...
2.
Masclee G, Straatman H, Arfe A, Castellsague J, Garbe E, Herings R, et al.
PLoS One
. 2018 Nov;
13(11):e0204746.
PMID: 30383755
Background: Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been associated with an increased risk of acute myocardial infarction (AMI). However, the risk of AMI has only been...
3.
Adverse drug reactions in a primary care population prescribed non-steroidal anti-inflammatory drugs
Koffeman A, R van Buul A, Valkhoff V, t Jong G, Bindels P, Sturkenboom M, et al.
Scand J Prim Health Care
. 2015 Jul;
33(3):163-9.
PMID: 26198810
Objective: To determine how often patients with musculoskeletal (MSK) complaints prescribed a non-steroidal anti-inflammatory drug (NSAID) subsequently consult their general practitioner (GP) with a non-serious adverse drug reaction (ADR). Design:...
4.
Warle-van Herwaarden M, Koffeman A, Valkhoff V, t Jong G, Kramers C, Sturkenboom M, et al.
Br J Clin Pharmacol
. 2015 Mar;
80(3):589-98.
PMID: 25777983
Aims: Low-dose aspirin (LDA) and non-steroidal-anti-inflammatory drugs (NSAIDs) both increase the risk of upper gastrointestinal events (UGIEs). In the Netherlands, recommendations regarding the prescription of gastroprotective agents (GPAs) in LDA...
5.
Warle-van Herwaarden M, Valkhoff V, Herings R, Engelkes M, van Blijderveen J, Rodenburg E, et al.
Pharmacoepidemiol Drug Saf
. 2015 Feb;
24(5):495-503.
PMID: 25683383
Purpose: To develop a computerized prescreening procedure for the identification of possible/probably Hospital Admissions potential Related to Medications (HARMs). Method: Pairs of drugs and reasons for hospitalization (generated automatically from...
6.
Masclee G, Valkhoff V, Coloma P, de Ridder M, Romio S, Schuemie M, et al.
Gastroenterology
. 2014 Jun;
147(4):784-792.e9.
PMID: 24937265
Background & Aims: Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin increases the risk of upper gastrointestinal bleeding (UGIB). Guidelines suggest avoiding certain drug combinations, yet little is...
7.
Koffeman A, Valkhoff V, Jong G, Warle-van Herwaarden M, Bindels P, Sturkenboom M, et al.
Scand J Prim Health Care
. 2014 Jun;
32(2):90-8.
PMID: 24931511
Objective: To determine the influence of ischaemic cardiovascular (CV) risk on prescription of non-steroidal anti-inflammatory drugs (NSAIDs) by general practitioners (GPs) in patients with musculoskeletal complaints. Design: Cohort study. Setting:...
8.
Valkhoff V, Coloma P, Masclee G, Gini R, Innocenti F, Lapi F, et al.
J Clin Epidemiol
. 2014 May;
67(8):921-31.
PMID: 24794575
Objective: To evaluate the accuracy of disease codes and free text in identifying upper gastrointestinal bleeding (UGIB) from electronic health-care records (EHRs). Study Design And Setting: We conducted a validation...
9.
Koffeman A, Valkhoff V, Celik S, Jong G, Sturkenboom M, Bindels P, et al.
Br J Gen Pract
. 2014 Apr;
64(621):e191-8.
PMID: 24686883
Background: The use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with serious adverse drug events (ADEs). Aim: To determine the prevalence of over-the-counter (OTC) NSAID use in the general population...
10.
Warle-van Herwaarden M, Valkhoff V, Teichert M, Koffeman A, t Jong G, Sturkenboom M, et al.
Expert Opin Drug Saf
. 2013 Dec;
13(2):157-65.
PMID: 24304132
Objective: The Dutch HARM-Wrestling (HW) Task Force issued general and drug-specific recommendations aimed at reducing hospital admissions related to medication (HARMs). This study examines if the drug-specific recommendations could be...